Advertisement
Advertisement
REGN
Regeneron Pharmaceuticals Inc
784.85
USDSponsored
-4.60
-0.58%
Sep 18, 15:59 UTC -4
Closed
After-Market
784.57
-0.28
-0.04%
Regeneron Pharmaceuticals Inc Financial Snapshot
| Market Cap | 80.77B |
| Beta | 0.20 |
| Earnings Per Share (EPS) | 40.46 |
| Price-to-Book (P/B) Ratio | 2.56 |
| Operating Margin | 27.17% |
| Total Debt/Equity (D/E) | 8.54% |
| P/E Ratio | 20.26 |
| Return on Equity (ROE) | 13.47% |
| Current Ratio | 3.34% |
| Free Cash Flow | 1.42B |
